Matches in Wikidata for { <http://www.wikidata.org/entity/Q91554266> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q91554266 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91554266 description "scientific article published on 18 September 2018" @default.
- Q91554266 description "wetenschappelijk artikel" @default.
- Q91554266 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91554266 name "Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data" @default.
- Q91554266 name "Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data" @default.
- Q91554266 type Item @default.
- Q91554266 label "Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data" @default.
- Q91554266 label "Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data" @default.
- Q91554266 prefLabel "Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data" @default.
- Q91554266 prefLabel "Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data" @default.
- Q91554266 P1433 Q91554266-0876F756-4E00-40B5-8E22-F8471A383F78 @default.
- Q91554266 P1476 Q91554266-FCE63639-B142-4225-BE1D-4E587A431655 @default.
- Q91554266 P2093 Q91554266-BE9C87DE-1686-4F21-850A-20F436DFD61F @default.
- Q91554266 P304 Q91554266-16CDA7D3-39EB-4B03-820E-3E09F5A60E52 @default.
- Q91554266 P31 Q91554266-F566FFEB-1609-49BF-9319-458F4A60470A @default.
- Q91554266 P356 Q91554266-E4AB35B9-10FF-4A89-AA85-9E5EDAC0F6C4 @default.
- Q91554266 P433 Q91554266-1AADFA9F-7ABF-4EE8-BF76-D5D33C6EBA7A @default.
- Q91554266 P478 Q91554266-16CEB5A3-8A04-4F14-AF50-454C161208D2 @default.
- Q91554266 P50 Q91554266-21DE8D5F-33BB-4B30-925F-92DC00408B28 @default.
- Q91554266 P577 Q91554266-9017353C-512C-4DB9-BB4F-FFF2DE474C78 @default.
- Q91554266 P698 Q91554266-F28A8573-88D7-4BD0-ABAD-9C5812203F00 @default.
- Q91554266 P356 CS20171374 @default.
- Q91554266 P698 30232238 @default.
- Q91554266 P1433 Q372419 @default.
- Q91554266 P1476 "Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data" @default.
- Q91554266 P2093 "Lars Rydén" @default.
- Q91554266 P304 "2003-2012" @default.
- Q91554266 P31 Q13442814 @default.
- Q91554266 P356 "10.1042/CS20171374" @default.
- Q91554266 P433 "18" @default.
- Q91554266 P478 "132" @default.
- Q91554266 P50 Q89807872 @default.
- Q91554266 P577 "2018-09-18T00:00:00Z" @default.
- Q91554266 P698 "30232238" @default.